In the GSE26972 dataset, human TRPV2 was significantly reduced in the entorhinal cortex samples of AD patients compared with the control patients (p = 0.035, Figure 1C), with no changes in the hippocampus, temporal cortex, and frontal cortex (all p > 0.05, Figure 1C). Here, TRPV2 is linked to Alzheimer disease.